The Architecture Billings Index (ABI) concluded the year in positive terrain, with the December reading capping off three straight months of growth in design billings.
The American Institute of Architects (AIA) reported the December ABI score was 52.9, down from a score of 55.0 in the previous month. This score still reflects an increase in design services provided by U.S. architecture firms (any score above 50 indicates an increase in billings).
The new projects inquiry index was 61.9, up from a reading of 61.1 the previous month, while the new design contracts index decreased slightly from 53.2 to 52.7.
“Overall, 2017 turned out to be a strong year for architecture firms,” said AIA Chief Economist, Kermit Baker, PhD, Hon. AIA. “All but two months saw ABI scores in positive territory. Additionally, the overall strength of the fourth quarter lays a good foundation for healthy growth in construction activity in 2018.”
Key December ABI highlights:
• Regional averages: South (56.3), West (53.0), Midwest (52.9), Northeast (49.4)
• Sector index breakdown: multi-family residential (55.4), commercial / industrial (54.8), institutional (51.2), mixed practice (50.4)
• Project inquiries index: 61.9
• Design contracts index: 53.2
The regional and sector categories are calculated as a three-month moving average, whereas the national index, design contracts and inquiries are monthly numbers.
Related Stories
| Sep 19, 2022
New York City construction site inspections, enforcement found ‘inadequate’
A new report by the New York State Comptroller found that New York City construction site inspections and regulation enforcement need improvement.
| Sep 16, 2022
Fairfax County, Va., considers impactful code change to reduce flood risk
Fairfax County, Va., in the Washington, D.C., metro region is considering a major code change to reduce the risk from floods.
Multifamily Housing | Sep 15, 2022
Heat Pumps in Multifamily Projects
RMI's Lacey Tan gives the basics of heat pumps and how they can reduce energy costs and carbon emissions in apartment projects.
| Sep 15, 2022
Monthly construction input prices dip in August
Construction input prices decreased 1.4% in August compared to the previous month, according to an Associated Builders and Contractors analysis of U.S. Bureau of Labor Statistics Producer Price Index data released today.
| Sep 15, 2022
First LEED Platinum, net zero and net zero water synagogue opens
Kol Emeth Center, the world’s first LEED Platinum, net zero and net zero water synagogue, opened recently in Palo Alto, Calif.
| Sep 14, 2022
Fires on Amazon warehouse roofs seemingly caused by faulty PV installations
Amazon has made installing solar panels on rooftops a key part of its ESG strategy, but a series of events last year show how challenging greening up major facilities can be.
| Sep 14, 2022
Indian tribe’s new educational campus supports culturally appropriate education
The Kenaitze Indian Tribe recently opened the Kahtnuht’ana Duhdeldiht Campus (Kenai River People’s Learning Place), a new education center in Kenai, Alaska.
| Sep 13, 2022
California building codes now allow high-rise mass-timber buildings
California recently enacted new building codes that allow for high-rise mass-timber buildings to be constructed in the state.
| Sep 13, 2022
Orange County opens civic center complex—one of California’s largest P3 projects
Orange County’s recently opened County Administration North (CAN) building caps an urban center development that constitutes one of California’s largest ever P3 projects.
Laboratories | Sep 12, 2022
Lab space scarcity propels construction demand in life sciences sector
In its 2021 Life Sciences Real Estate Outlook, JLL predicted that access to talent would be a primary concern for an industry sector that had been growing by leaps and bounds. A year later, talent still guides real estate decisions. But market conditions of a different sort were cooling the biotech field: namely, investors that have soured on startups which underperformed after going public. What this means for new construction and renovation going forward is unpredictable, as the drivers behind life sciences’ surge are still palpable.
